Virax Biolabs (UK) Limited LONDON


Virax Biolabs (UK) Limited is a private limited company registered at 20 North Audley Street, London W1K 6LX. Its net worth is estimated to be roughly 0 pounds, while the fixed assets the company owns amount to 0 pounds. Incorporated on 2021-09-20, this 2-year-old company is run by 1 director.
Director James F., appointed on 20 September 2021.
The company is classified as "activities of other holding companies n.e.c." (SIC code: 64209).
The last confirmation statement was filed on 2022-09-19 and the date for the next filing is 2023-10-03. Furthermore, the annual accounts were filed on 31 March 2022 and the next filing should be sent on 30 December 2023.

Virax Biolabs (UK) Limited Address / Contact

Office Address 20 North Audley Street
Town London
Post code W1K 6LX
Country of origin United Kingdom

Company Information / Profile

Registration Number 13630639
Date of Incorporation Mon, 20th Sep 2021
Industry Activities of other holding companies n.e.c.
End of financial Year 30th March
Company age 3 years old
Account next due date Sat, 30th Dec 2023 (145 days after)
Account last made up date Thu, 31st Mar 2022
Next confirmation statement due date Tue, 3rd Oct 2023 (2023-10-03)
Last confirmation statement dated Mon, 19th Sep 2022

Company staff

James F.

Position: Director

Appointed: 20 September 2021

Cameron S.

Position: Secretary

Appointed: 20 February 2023

Resigned: 31 August 2023

People with significant control

The register of persons with significant control who own or control the company is made up of 3 names. As BizStats established, there is Virax Biolabs Group Limited from Grand Cayman, United Kingdom. The abovementioned PSC is categorised as "a private company limited by shares exempt under section 60" and has 75,01-100% shares. The abovementioned PSC and has 75,01-100% shares. The second one in the persons with significant control register is James F. This PSC and has 25-50% voting rights. The third one is Cameron S., who also fulfils the Companies House criteria to be categorised as a PSC. This PSC and has 25-50% voting rights.

Virax Biolabs Group Limited

89 Nexus Way Camana Bay, Grand Cayman, KY1 - 9009, United Kingdom

Legal authority Companies Act 2006
Legal form Private Company Limited By Shares Exempt Under Section 60
Country registered Cayman Islands
Place registered Cayman Islands
Registration number 380440
Notified on 21 July 2022
Nature of control: 75,01-100% shares

James F.

Notified on 20 April 2022
Ceased on 21 July 2022
Nature of control: 25-50% voting rights

Cameron S.

Notified on 20 April 2022
Ceased on 21 July 2022
Nature of control: 25-50% voting rights

Annual reports financial information

Profit & Loss
Accounts Information Date 2022-03-312023-03-31
Balance Sheet
Cash Bank On Hand 2 516 525
Current Assets542 516 965
Debtors54440
Other Debtors54440
Other
Accrued Liabilities Deferred Income 105 617
Accumulated Amortisation Impairment Intangible Assets 152 709
Additions Other Than Through Business Combinations Intangible Assets 144 244
Administrative Expenses2 610969 004
Amortisation Impairment Expense Intangible Assets 152 709
Amounts Owed To Group Undertakings8 3653 191 534
Average Number Employees During Period14
Cash Cash Equivalents Cash Flow Value 2 516 525
Creditors11 0293 333 242
Fixed Assets9 163698
Further Item Cash Flow From Used In Financing Activities Component Net Cash Flows From Used In Financing Activities -3 183 169
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss 29 079
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables-11 029 
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables54386
Impairment Loss Intangible Assets 152 709
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation -2 516 525
Increase From Impairment Loss Recognised In Profit Or Loss Intangible Assets 152 709
Intangible Assets8 465 
Intangible Assets Gross Cost8 465152 709
Investments Fixed Assets698698
Investments In Subsidiaries698698
Issue Equity Instruments100 
Net Cash Generated From Operations-8 365522 400
Net Current Assets Liabilities-10 975-816 277
Other Creditors1224 867
Pension Other Post-employment Benefit Costs Other Pension Costs 1 117
Percentage Class Share Held In Subsidiary 100
Proceeds From Issuing Shares-100 
Profit Loss-2 610-969 004
Profit Loss On Ordinary Activities Before Tax-2 610-969 004
Purchase Intangible Assets-8 465-144 244
Staff Costs Employee Benefits Expense 458 560
Total Assets Less Current Liabilities-2 510-815 579
Trade Creditors Trade Payables2 65211 224

Company filings

Filing category
Accounts Address Confirmation statement Incorporation Officers Persons with significant control
Confirmation statement with no updates Tue, 19th Sep 2023
filed on: 1st, November 2023
Free Download (3 pages)

Company search